GPX Medical is one of several successful spin-off companies from Biophotonics in Lund, addressing the needs of better care for our patients.

On April 5th 2019 GPX Medical, represented by Chairman of the Board Märta Lewander Xu, CEO Hanna Sjöström and CTO Sara Bergsten, participated in a workshop held by Lund University Medical Lacer Center’s manager Professor Bo Baldetorp, Chairman of the Board Professor Katarina Svanberg and Professor Sune Svanberg, with the aim of understanding the challenges clinicians face today which needs tomorrow’s advanced solutions.

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB (publ)
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se

Organization number: 559069-9012